Canada markets closed

Tarsus Pharmaceuticals, Inc. (TARS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
37.00+2.96 (+8.70%)
At close: 04:00PM EDT
37.65 +0.65 (+1.76%)
After hours: 07:44PM EDT
Show:
Income Statement
Cash Flow
Annual

Balance Sheet

All numbers in thousands
Breakdown
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Assets
Current Assets
Cash
Cash And Cash Equivalents
224,947
71,660
171,332
168,129
Other Short Term Investments
2,495
145,366
483
0
Total Cash
227,442
217,026
171,815
168,129
Net Receivables
16,621
0
-
-
Inventory
3,107
0
-
-
Total Current Assets
256,131
225,375
175,952
170,655
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
4,638
2,078
2,050
1,370
Accumulated Depreciation
-1,290
-546
-221
-134
Net property, plant and equipment
3,348
1,532
1,829
1,236
Equity and other investments
631
371
0
-
Other long-term assets
1,514
585
392
81
Total non-current assets
9,360
2,488
2,955
1,317
Total Assets
265,491
227,863
178,907
171,972
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Accounts Payable
18,149
5,498
2,856
2,237
Taxes payable
-
14
55
0
Accrued liabilities
18,389
9,210
7,205
2,564
Total Current Liabilities
36,936
15,429
11,478
5,387
Non-current liabilities
Long Term Debt
29,819
19,434
-
-
Other long-term liabilities
1,748
100
-
-
Total non-current liabilities
31,567
19,534
699
605
Total Liabilities
68,503
34,963
12,177
5,992
Stockholders' Equity
Common Stock
5
5
4
4
Retained Earnings
-244,656
-108,763
-46,672
-32,845
Accumulated other comprehensive income
-2
-74
0
-
Total stockholders' equity
196,988
192,900
166,730
165,980
Total liabilities and stockholders' equity
265,491
227,863
178,907
171,972